Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.

about

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.

Item

http://www.wikidata.org/entity/Q52802735

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@en

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@nl

type

Item

label

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@en

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@nl

prefLabel

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@en

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@nl

P1154

2-s2.0-85043598969

http://www.w3.org/2001/XMLSchema#string

P1433

European Journal of Cancer

P1476

Epstein-Barr virus and mismatc ...... r: A large multi-centre study.

@en

P2093

A Hoelscher

http://www.w3.org/2001/XMLSchema#string

A Quaas

http://www.w3.org/2001/XMLSchema#string

E Bollschweiler

http://www.w3.org/2001/XMLSchema#string

G E Fazzi

http://www.w3.org/2001/XMLSchema#string

G G Hutchins

http://www.w3.org/2001/XMLSchema#string

H I Grabsch

http://www.w3.org/2001/XMLSchema#string

I Z Inam

http://www.w3.org/2001/XMLSchema#string

L C Hewitt

http://www.w3.org/2001/XMLSchema#string

M Nankivell

http://www.w3.org/2001/XMLSchema#string

R E Langley

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Comprehensive molecular characterization of gastric adenocarcinoma

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Comparative genomic hybridisation

P304

104-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJCA.2018.02.014

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

P5530

38236071

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101566382

http://www.w3.org/2001/XMLSchema#string

P698

29550565

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

5914544

http://www.w3.org/2001/XMLSchema#string

P953

127577/